Skip to main content
Article
Retrospective Cohort Study of the Efficacy of Azithromycin Vs. Doxycycline as Part of Combination Therapy in Non-Intensive Care Unit Veterans Hospitalized with Community-Acquired Pneumonia
Open Forum Infectious Diseases
  • Justin Spivey
  • Heather Sirek, Mountain Home VA Healthcare System
  • Robert Wood, Mountain Home VA Healthcare System
  • Kalpit Devani, East Tennessee State University
  • Billy Brooks, East Tennessee State University
  • Jonathan Moorman, Mountain Home VA Healthcare System
Document Type
Article
Publication Date
10-1-2017
Description

The IDSA Community-Acquired Pneumonia (CAP) Guideline recommends ceftriaxone in combination with doxycycline as an alternative to combination therapy with ceftriaxone and azithromycin for non-intensive care unit (ICU) patients hospitalized with CAP. This is an attractive alternative regimen due to recent concerns of increased cardiovascular risk associated with azithromycin. The objective of this study was to compare the clinical outcomes of azithromycin and doxycycline each in combination with ceftriaxone for non-ICU Veterans hospitalized with CAP.

Copyright Statement

© The Author 2017. This document was originally published in Open Forum Infectious Diseases.

Citation Information
Justin Spivey, Heather Sirek, Robert Wood, Kalpit Devani, et al.. "Retrospective Cohort Study of the Efficacy of Azithromycin Vs. Doxycycline as Part of Combination Therapy in Non-Intensive Care Unit Veterans Hospitalized with Community-Acquired Pneumonia" Open Forum Infectious Diseases Vol. 4 (2017) p. 579 - 580
Available at: http://works.bepress.com/billy-brooks/17/